Device type · QJP
Catheter, Percutaneous, Neurovasculature
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QJP
Neurology
Device class
Class II
FDA decisions since 2015
104
510(k), De Novo and PMA
Adverse event reports
1,129
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Catheter, Percutaneous, Neurovasculature
- Product code
- QJP
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 870.1250
- FDA record
- Classification database entry for QJP
Latest FDA decisions
The 8 newest of 104 since 2015.
- NeuroSheath510(k)
K261449 · Decided Nov 5, 2026 · 188 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K261649 · Decided Oct 9, 2026 · 143 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
- APRO 88 Catheter510(k)
K261938 · Decided Oct 6, 2026 · 118 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
- OAB Delivery Catheter510(k)
K253422 · Decided Oct 2, 2026 · 366 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K260220 · Decided Sep 16, 2026 · 233 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
- 70 NeuGlide Catheter510(k)
K262277 · Decided Sep 4, 2026 · 60 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
- Zoom 4S Catheter510(k)
K261176 · Decided Aug 28, 2026 · 140 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
- p17 XR Microcatheter510(k)
K254071 · Decided Aug 18, 2026 · 243 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
Reports received
1,129
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
1,002
89% of reports
Injury reports
104
9.2% of reports
Death reports
23
2.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 4 | 5 | 1 | 0 |
| Jan 24 | 8 | 8 | 2 | 0 |
| Feb 24 | 22 | 5 | 0 | 0 |
| Mar 24 | 2 | 7 | 0 | 0 |
| Apr 24 | 5 | 1 | 0 | 0 |
| May 24 | 1 | 1 | 0 | 0 |
| Jun 24 | 6 | 5 | 0 | 0 |
| Jul 24 | 6 | 2 | 1 | 0 |
| Aug 24 | 3 | 4 | 0 | 0 |
| Sep 24 | 4 | 1 | 0 | 0 |
| Oct 24 | 6 | 3 | 1 | 0 |
| Nov 24 | 3 | 9 | 0 | 0 |
| Dec 24 | 12 | 5 | 0 | 0 |
| Jan 25 | 5 | 6 | 0 | 0 |
| Feb 25 | 7 | 8 | 0 | 0 |
| Mar 25 | 14 | 9 | 1 | 0 |
| Apr 25 | 18 | 6 | 1 | 0 |
| May 25 | 20 | 11 | 0 | 0 |
| Jun 25 | 62 | 17 | 2 | 0 |
| Jul 25 | 86 | 11 | 0 | 0 |
| Aug 25 | 80 | 6 | 3 | 0 |
| Sep 25 | 57 | 13 | 1 | 0 |
| Oct 25 | 63 | 5 | 3 | 0 |
| Nov 25 | 78 | 9 | 4 | 0 |
| Dec 25 | 86 | 9 | 1 | 0 |
| Jan 26 | 107 | 4 | 0 | 0 |
| Feb 26 | 71 | 10 | 1 | 0 |
| Mar 26 | 92 | 18 | 8 | 0 |
| Apr 26 | 87 | 7 | 4 | 0 |
| May 26 | 76 | 2 | 0 | 0 |
| Jun 26 | 83 | 8 | 0 | 0 |
| Jul 26 | 100 | 8 | 0 | 0 |
| Aug 26 | 85 | 14 | 3 | 0 |
| Sep 26 | 75 | 12 | 2 | 0 |
| Oct 26 | 62 | 3 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Physical Resistance/Sticking651
- Retraction Problem268
- Adverse Event Without Identified Device or Use Problem100
- Material Twisted/Bent74
- Material Deformation64
- Difficult to Advance61
- Break56
- Unintended Movement50
- Crack30
- Difficult to Remove23
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions999
- Ischemia Stroke38
- Intracranial Hemorrhage33
- Foreign Body In Patient21
- Obstruction/Occlusion14
- Aneurysm13
- Ruptured Aneurysm13
- Headache12
- Thromboembolism12
- Vasoconstriction12
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1235-2025 · Started Jan 16, 2025 · Posted by FDA Feb 26, 2025
Reason given: Due to manufacturing non-conformance that resulted in channels in the seal on the packaging pouch. As a result, this could potential create a breach in the sterile barrier.
Cause as FDA categorized it: Under Investigation by firm
Z-0021-2025 · Started Aug 30, 2024 · Posted by FDA Oct 7, 2024
Reason given: Stryker Neurovascular has observed that devices with Out of United States (OUS) approved Instructions for Use (IFU) and Packaging Labels (pouch and carton), different configurations, have been erroneously distributed to customers in the US.
Cause as FDA categorized it: Under Investigation by firm
- Trevo Trak 21 Microcatheter, Catalog: 90338Open, Classified
Z-1906-2024 · Started Apr 23, 2024 · Posted by FDA May 28, 2024
Reason given: Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so these devices may exceed the acceptable limits of endotoxin levels; high levels of endotoxins may increase the risk of fever, shock and...
Cause as FDA categorized it: Process design
Z-1610-2024 · Started Mar 8, 2024 · Posted by FDA Apr 24, 2024
Reason given: Their is the potential for distal tip separation at the proximal marker band of the delivery catheters.
Cause as FDA categorized it: Process control
- Route 92 Medical, 070 Access System, REF 1004, Rxonly , Sterile EO. Used for introduction of interventional devices into the neurovasculature.Open, Classified
Z-1612-2024 · Started Mar 8, 2024 · Posted by FDA Apr 24, 2024
Reason given: Their is the potential for distal tip separation at the proximal marker band of the delivery catheters
Cause as FDA categorized it: Process control
- CERENOVUS CEREBASE DA Guide Sheath, Part Numbers: a) GS9080SD; b) GS9090SD; c) GS9095SD; Vascular guide-catheter, single-useOpen, Classified
Z-1284-2024 · Started Feb 2, 2024 · Posted by FDA Mar 13, 2024
Reason given: Medos has received an increase in complaints for CEREBASE DA Guide Sheath with reports of fractures at the distal end, which may result in surgical procedural delay, vascular injury and in extreme rare occasions it may result in embolism.
Cause as FDA categorized it: Under Investigation by firm
Z-1085-2024 · Started Dec 6, 2023 · Posted by FDA Feb 14, 2024
Reason given: The microcatheter IFU contains an intended use that has not been evaluated by the FDA.
Cause as FDA categorized it: Under Investigation by firm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.